ChEBI: A maleate salt obtained by combining proglumetacin with two molar equivalents of maleic acid. Used to control pain and inflammation associated with musculoskeletal and joint disorders. Following oral adminitration, it is metabolied to indometacin and progl
mide, a drug with antisecretory effects that helps prevent injury to the stomach lining.
Proglumetacin at a dose of 450 mg/d appears
to be as effective as 150 mg/d of indomethacin
in the treatment of a wide variety of rheumatic
conditions, and is faster acting with significantly
lower incidence and severity of adverse effects.
It is metabolized to several derivatives, including
indomethacin, in humans.
Afloxan (Rotta Research,
Italy), Protaxil (Rottapharm, Spain), Protaxon
(Opfermann, Germany), Proxil (Rottapharm,
Italy), Tolindol (La Meuse, Belgium).
alkylation of the anticholinergic agent proglumide with N-(3-chloropropyl)-N'-(2-hydroxyethyl)piperazine using
sodium methoxide in dimethyl sulfoxide gives N-[3-(N-benzoyl-N' ,N '-di-npropyl-dl-isoglutaminyl)oxypropyl]-N'-(2-
hydroxyethyl)piperazine, which is then condensed with indomethacin using dicyclohexylcarbodiimide. The resulting ester is treated
with maleic acid to give proglumetacin maleate.
